HK1121232A1 - Method for porcine circovirus production and assays for monitoring production - Google Patents

Method for porcine circovirus production and assays for monitoring production

Info

Publication number
HK1121232A1
HK1121232A1 HK08112728.6A HK08112728A HK1121232A1 HK 1121232 A1 HK1121232 A1 HK 1121232A1 HK 08112728 A HK08112728 A HK 08112728A HK 1121232 A1 HK1121232 A1 HK 1121232A1
Authority
HK
Hong Kong
Prior art keywords
production
assays
porcine circovirus
monitoring
monitoring production
Prior art date
Application number
HK08112728.6A
Other languages
English (en)
Inventor
Patrice Allibert
Lionel Pierre Cupillard
Jean Reyes
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of HK1121232A1 publication Critical patent/HK1121232A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02Recovery or purification
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/10011Circoviridae
    • C12N2750/10051Methods of production or purification of viral material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK08112728.6A 2005-04-13 2008-11-21 Method for porcine circovirus production and assays for monitoring production HK1121232A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67089205P 2005-04-13 2005-04-13
PCT/US2006/014068 WO2006113435A2 (en) 2005-04-13 2006-04-13 Method for porcine circovirus production and assays for monitoring production

Publications (1)

Publication Number Publication Date
HK1121232A1 true HK1121232A1 (en) 2009-04-17

Family

ID=37115731

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08112728.6A HK1121232A1 (en) 2005-04-13 2008-11-21 Method for porcine circovirus production and assays for monitoring production

Country Status (21)

Country Link
US (2) US7358075B2 (el)
EP (2) EP1869471B1 (el)
JP (1) JP5408998B2 (el)
KR (1) KR101369656B1 (el)
CN (1) CN101194165B (el)
BR (1) BRPI0607540B1 (el)
CA (1) CA2604691C (el)
CR (1) CR9511A (el)
CY (1) CY1117850T1 (el)
DK (1) DK1869471T3 (el)
ES (1) ES2589928T3 (el)
HK (1) HK1121232A1 (el)
HR (1) HRP20161132T1 (el)
HU (1) HUE028343T2 (el)
ME (1) ME02683B (el)
MX (1) MX2007012786A (el)
PL (1) PL1869471T3 (el)
PT (1) PT1869471T (el)
RS (1) RS55085B1 (el)
SI (1) SI1869471T1 (el)
WO (1) WO2006113435A2 (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7700285B1 (en) * 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) * 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US20080226594A1 (en) * 2005-02-03 2008-09-18 Hans Nauwynck Culturing circular ssdna viruses for the production of vaccines
EP1968630B1 (en) 2005-12-29 2018-01-24 Boehringer Ingelheim Vetmedica, Inc. Multivalent pcv2 immunogenic compositions
DK3127551T3 (da) 2005-12-29 2020-10-12 Boehringer Ingelheim Animal Health Usa Inc Pcv2-immunogen-sammensætning til at mindske kliniske symptomer i grise
US20100129397A1 (en) * 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
PT2481420T (pt) * 2006-12-15 2019-05-31 Boehringer Ingelheim Animal Health Usa Inc Vacina para porcos anti-pcv2 de dose única
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US8330873B2 (en) * 2007-03-14 2012-12-11 Larry Silver Signal demodulator with overmodulation protection
AU2007353480B2 (en) * 2007-05-11 2013-09-19 Temasek Life Sciences Laboratory Limited Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection
US7829274B2 (en) * 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
JP2011508595A (ja) * 2007-12-31 2011-03-17 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド 外来性アミノ酸の挿入を含むpcv2orf2ウイルス様粒子
US20090317423A1 (en) * 2008-01-23 2009-12-24 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物
CN101773667A (zh) * 2010-01-28 2010-07-14 洛阳普莱柯生物工程有限公司 一种猪圆环病毒ii型疫苗制备
CN102690790B (zh) * 2012-04-27 2013-09-25 成都天邦生物制品有限公司 猪圆环病毒2型细胞悬浮培养生产方法
EP2994162B1 (en) 2013-05-08 2021-04-07 Pharmgate Biologics Inc. Vaccine for pcv2 and mycoplasma
JP6821429B2 (ja) 2013-09-25 2021-01-27 ゾエティス・サービシーズ・エルエルシー Pcv2b分岐ワクチン組成物及び使用方法
US9505808B2 (en) 2013-10-02 2016-11-29 Boehringer Ingelheim Vetmedica, Inc. PCV2 ORF2 protein variant and virus like particles composed thereof
US10663468B2 (en) 2015-07-24 2020-05-26 Boehringer Ingelheim Animal Health USA Inc. High throughput methods for virus quantification
DE102018100967B4 (de) 2018-01-17 2019-08-14 Immatics US, Inc. Verfahren zur feststellung der wirksamkeit von viralen vektoren
DE102018010282A1 (de) 2018-01-17 2019-07-18 Immatics US, Inc. Verfahren zur Feststellung der Wirksamkeit von viralen Vektoren

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391314B1 (en) * 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
UA78180C2 (uk) * 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
EP1111040A1 (en) * 1999-12-10 2001-06-27 Daniel Favre Infection of eukaryotic cells with viruses in vitro
AU2001266940A1 (en) * 2000-06-15 2001-12-24 Purdue Research Foundation Vaccine for congenital tremors in pigs
DE10044648A1 (de) * 2000-09-08 2002-03-21 Aventis Behring Gmbh Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material
EP1520008B1 (en) * 2002-07-09 2012-09-05 Baxter International Inc. Animal protein free media for cultivation of cells
CA2517181C (en) * 2003-02-25 2013-07-16 Medimmune Vaccines, Inc. Methods of producing influenza vaccine compositions

Also Published As

Publication number Publication date
US20080241821A1 (en) 2008-10-02
ES2589928T3 (es) 2016-11-17
WO2006113435A2 (en) 2006-10-26
CR9511A (es) 2008-01-29
CA2604691A1 (en) 2006-10-26
CY1117850T1 (el) 2017-05-17
EP1869471B1 (en) 2016-06-08
BRPI0607540A2 (pt) 2009-09-15
US7358075B2 (en) 2008-04-15
EP3088893B1 (en) 2018-02-14
ME02683B (me) 2017-06-20
RS55085B1 (sr) 2016-12-30
MX2007012786A (es) 2008-01-11
CN101194165A (zh) 2008-06-04
SI1869471T1 (sl) 2016-09-30
BRPI0607540B1 (pt) 2017-05-09
US20060246425A1 (en) 2006-11-02
HUE028343T2 (en) 2016-12-28
CA2604691C (en) 2013-12-31
KR20070120603A (ko) 2007-12-24
PT1869471T (pt) 2016-08-16
WO2006113435A3 (en) 2007-06-21
EP3088893A1 (en) 2016-11-02
JP5408998B2 (ja) 2014-02-05
JP2008536499A (ja) 2008-09-11
HRP20161132T1 (hr) 2016-12-02
EP1869471A2 (en) 2007-12-26
PL1869471T3 (pl) 2017-02-28
DK1869471T3 (en) 2016-08-01
US7476507B2 (en) 2009-01-13
CN101194165B (zh) 2013-01-09
KR101369656B1 (ko) 2014-03-04

Similar Documents

Publication Publication Date Title
HK1121232A1 (en) Method for porcine circovirus production and assays for monitoring production
EP1857532A4 (en) SOLID BIOMASS AND PROCESS FOR PRODUCING THE SAME
SI2115217T1 (sl) Sito za odstranjevanje vode in postopek njegove izdelave
ZA200710049B (en) Method for producing betamimetics
HK1122008A1 (en) Method for operating lift installation and the lift installation for carrying out the method
EP1921122A4 (en) DAMPING MATERIAL AND MANUFACTURING METHOD THEREFOR
ZA200707686B (en) Method for producing catalytically-active materials
GB0523019D0 (en) Automated immunoassay apparatus
EP1860120A4 (en) PROCESS FOR AN IMPROVED ANTIBODY
EP1875154A4 (en) PROCESS FOR PREDICTIVE MAINTENANCE
HK1116233A1 (en) Method and apparatus for monitoring gateroad structural change
GB0610148D0 (en) Glazing inspection method
GB0514678D0 (en) Method for high-throughput screening
EP1860185A4 (en) SCREENING METHOD
EP1858255A4 (en) BACKGROUND REPLACEMENT DEVICE, BACKGROUND REPLACEMENT PROGRAM, AND BACKGROUND REPLACEMENT METHOD
EP1857817A4 (en) SCREENING PROCESS
EP1954816A4 (en) METHOD FOR ASSESSING MICROORGANISMS IN THE AIR
GB0607031D0 (en) Monitoring method
EP1997902A4 (en) SCREENING PROCESS
GB0502065D0 (en) Assay method
EP1860439A4 (en) IMMUNODOSING METHOD AND CORRESPONDING REAGENT
GB0610542D0 (en) Screening method
GB0511893D0 (en) Assay method
GB0612712D0 (en) Novel screening method
GB0514674D0 (en) Method for high-throughput screening